Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph W Kim

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Community Oncology|October 3, 2012
ASCO beyond McCormick: perseverance, collaboration, mentorshipJoseph W Kim
Current Oncology Reports|August 5, 2022
Emerging Role of PARP Inhibitors in Metastatic Prostate CancerSerhan Unlu, Joseph W Kim
Oncology (Williston Park, N.Y.)|November 27, 2012
Improving harmonious precisionJoseph W Kim, John L Marshall
Oncology (Williston Park, N.Y.)|November 13, 2014
Prospects for targeting PD-1 and PD-L1 in various tumor typesJoseph W Kim, Joseph Paul Eder
Expert Opinion on Biological Therapy|March 15, 2012
Poxviral vectors for cancer immunotherapyJoseph W Kim, James L Gulley
International Journal of Radiation Oncology, Biology, Physics|December 4, 2023
Go for Broke!James B Yu, Joseph W Kim
Oncology (Williston Park, N.Y.)|November 19, 2014
Mechanisms of immunotherapy resistance in mCRPC: identifying the enemy on the visceral metastatic battlefieldJoseph W Kim, Marijo Bilusic, Elizabeth R Plimack
Journal of Bioanalysis & Biomedicine|May 16, 2017
The Biochemical Cascades of the Human Pancreatic <i>β</i>-Cells: The Role of MicroRNAsJoseph W Kim, John Z Luo, Luguang Luo
Clinical Genitourinary Cancer|October 25, 2011
Initial PSA oscillations precede prolonged stable disease in a patient treated with a therapeutic cancer vaccineJoseph W Kim, Ravi A Madan, James L Gulley
European Journal Pharmaceutical and Medical Research|August 23, 2016
EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITROJohn Z Q Luo, Joseph W Kim, LuGuang Luo
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Community Oncology|October 3, 2012
ASCO beyond McCormick: perseverance, collaboration, mentorshipJoseph W Kim
Current Oncology Reports|August 5, 2022
Emerging Role of PARP Inhibitors in Metastatic Prostate CancerSerhan Unlu, Joseph W Kim
Oncology (Williston Park, N.Y.)|November 27, 2012
Improving harmonious precisionJoseph W Kim, John L Marshall
Oncology (Williston Park, N.Y.)|November 13, 2014
Prospects for targeting PD-1 and PD-L1 in various tumor typesJoseph W Kim, Joseph Paul Eder
Expert Opinion on Biological Therapy|March 15, 2012
Poxviral vectors for cancer immunotherapyJoseph W Kim, James L Gulley
International Journal of Radiation Oncology, Biology, Physics|December 4, 2023
Go for Broke!James B Yu, Joseph W Kim
Oncology (Williston Park, N.Y.)|November 19, 2014
Mechanisms of immunotherapy resistance in mCRPC: identifying the enemy on the visceral metastatic battlefieldJoseph W Kim, Marijo Bilusic, Elizabeth R Plimack
Journal of Bioanalysis & Biomedicine|May 16, 2017
The Biochemical Cascades of the Human Pancreatic <i>β</i>-Cells: The Role of MicroRNAsJoseph W Kim, John Z Luo, Luguang Luo
Clinical Genitourinary Cancer|October 25, 2011
Initial PSA oscillations precede prolonged stable disease in a patient treated with a therapeutic cancer vaccineJoseph W Kim, Ravi A Madan, James L Gulley
European Journal Pharmaceutical and Medical Research|August 23, 2016
EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITROJohn Z Q Luo, Joseph W Kim, LuGuang Luo
Pageof 4